Australian Technical Advisory Group on Immunisation (ATAGI)
The Australian Technical Advisory Group on Immunisation (ATAGI) advises the Minister for Health on the National Immunisation Program (NIP) and other immunisation issues.
ATAGI's role is to:
- advise the Minister for Health on the medical administration of vaccines available in Australia, including those available through the National Immunisation Program (NIP)
- provide advice to research organisations on current immunisation research and areas that need more research
- advise the Pharmaceutical Benefits Advisory Committee (PBAC) on vaccine effectiveness and use in Australia
(see parallel processing requirements for PBAC vaccine submissions and guidelines for PBAC vaccine submissions)
- consult with relevant organisations to produce the Australian Immunisation Handbook
- consult with relevant organisations in implementing immunisation policies, procedures and vaccine safety.
For more detail, take a look at:
ATAGI members as at August 2018.
|Name||Area of expertise||Position|
|A/ Prof Christopher Blyth||Co-Chair, Paediatric infectious diseases, Clinical microbiology||Paediatrician Infectious Diseases Physician and Clinical Microbiologist
University of Western Australia, Telethon Kids Institute, Perth Children's Hospital and PathWest Laboratory
|Prof Allen Cheng||Co-Chair, Adult infectious disease, Epidemiology, Public health||Infectious Disease Physician and Director
Infection Prevention Healthcare Epidemiology Unit, Alfred Health
|A/Prof Nigel Crawford||Vaccine safety, Special risk groups||Director
Surveillance of Adverse Events Following Vaccination In the Community (SAEFVIC) Murdoch Children’s Research Institute
Head Immunisation Services Royal Children’s Hospital, Melbourne
|A/ Prof Michelle Giles||Adult Immunisation and Antenatal infectious disease||Infectious Diseases Physician (Alfred Health, Monash Health, Royal Women’s Hospital, Sunshine Hospital)
Adult Immunisation Physician (Monash Health, Sunshine Hospital)
|Ms Madeline Hall||Public health nurse, Vaccination procedures||Nurse Practitioner on ATAGI, Queensland Health|
|Prof David Isaacs||Use of vaccines and immunobiological agents in clinical practice and preventive medicine||Clinical Professor
Paediatrics & Child Health, Children's Hospital Westmead, University of Sydney
|Prof Helen Marshall||Clinical and clinical trial/vaccine and infectious diseases research expertise||Senior Medical Practitioner, Adelaide Women’s & Children’s Hospital|
|Prof Jodie McVernon||Research, Clinical, Laboratory vaccine research||Professor and Director of Doherty Epidemiology, the Peter Doherty Institute for Infection and Immunity, the University of Melbourne and the Royal Melbourne Hospital|
|Ms Debra Petrys||Consumer representative||Consumers Health Forum|
|Dr Nicholas Silberstein||General practice||General Practitioner on ATAGI, Victoria|
|Name||Area of expertise||Position|
|Dr Masha Somi||Representative from Department of Health||Assistant Secretary
Department of Health
|Dr Sonya Bennett||Communicable Diseases Network of Australia (CDNA)||Executive Director
Communicable Disease Branch, Queensland Health
|Dr Ting Lu||Representative from the Therapeutic Goods Administration||Office of Medicines Authorisation
Market Authorisation Group, Therapeutic Goods Administration
|Prof Kristine Macartney||National Centre for Immunisation Research and Surveillance (NCIRS)||Director
National Centre for Immunisation Research and Surveillance
Paediatrician and Infectious diseases Specialist
|Ms Karen Peterson||National Immunisation Committee (NIC)
National Immunisation Committee (NIC) nominee on ATAGI
|Manager Immunisation Program, Department of Health, Queensland|
- ATAGI conflict of interest disclosures
- ATAGI conflict of interest procedures
- ATAGI policies and procedures, effective 1 July 2019
ATAGI meet three times a year in February, June and October. Additional meetings may be held if needed.
Meeting agendas and bulletins (minutes) are organised by year.
If you require earlier editions of ATAGI agendas or bulletins please contact us.
- October: 67th meeting agenda, 67th meeting bulletin
- June: 66th meeting agenda, 66th meeting bulletin
- February: 65th meeting agenda, 65th meeting bulletin
- November: Special meeting agenda, Special meeting bulletin
- October: 64th meeting agenda, 64th meeting bulletin
- June: 63rd meeting agenda, 63rd meeting bulletin
- February: 62nd meeting agenda, 62nd meeting bulletin
- October: 61st meeting agenda, 61st meeting bulletin
- June: 60th meeting agenda, 60th meeting bulletin
- February: 59th meeting agenda, 59th meeting bulletin
Related committees and groups
ATAGI sets up working parties to look at diseases that can be prevented by vaccines and the future development of the Australian Immunisation Handbook.
Working parties prepare advice that is based on strong evidence and focused on the needs of the community. This includes reviewing and interpreting evidence on the effectiveness of vaccines. They provide this advice to the Department of Health and the Pharmaceutical Benefits Advisory Committee (PBAC). Their advice is also used by ATAGI in its recommendations on vaccine use in the Australian Immunisation Handbook.
Each of the working parties/groups is chaired by an ATAGI member and includes experts in that working party or group's area of focus. Sometimes, a sub-group of the working party may take on pieces of specific work about specific issues.
View the purpose and members of the ATAGI Working Parties.
Australian Technical Advisory Group on Immunisation (ATAGI) secretariat
Contact the secretariat for the Advisory Technical Advisory Group on Immunisation (ATAGI) or further information on the committee or previous meeting agendas and bulletins (meeting minutes)